While implantable cardioverter-defibrillators (ICDs) have been known to reduce mortality rates in patients, an analysis of four manufactured devices published in the December edition of the Heart Rhythm Journal found that upgrades to these devices are needed in order to further improve patient care.

Compressus has received a notice of allowance from the U.S. Patent & Trademark Office for its patent application, which represents thefoundational medical message routing technologies that allow the Compressus MEDxConnect system to provide a virtualized workflow environment to healthcare providers.

Post-traumatic stress symptoms may present a neurofunctional marker of decreased activity of the hippocampus in youth with a history of interpersonal trauma, said a new study's lead author Victor Carrion, MD, child psychiatrist and associate professor of the department of psychiatry and behavioral sciences at Stanford University in Calif., and his colleagues.

Intra-amygdala abnormalities and engagement of a compensatory frontoparietal executive control network, which are cognitive theories of generalized anxiety disorders (GADs) were consistent with the findings of a study published in the December edition of Archives of General Psychiatry, which studied the functional connectivity at a subregional level in the human brain that may mark GADs.

Diffusion tensor imaging (DTI) and white matter tractography successfully identifies white matter fibers stemming from the precentral gyrus prior to surgery within the posterior limb of the internal capsule in children with thalamic juvenile pilocytic astrocytomas, or benign tumors in the thalamus of the brain, said a study published in the December issue of Journal of Neurosurgery: Pediatrics.

Information and image software and services company, peerVue and medical imaging and workflow solutions company, ScImage have formed an integration agreement.

Medical software developer Medipattern and Sentinelle Medical, a manufacturer of MRI coils and advanced visualization software, are entering a technology access and distribution agreement.

One out of five patients with peripheral arterial disease (PAD) also has significant but silent coronary artery disease (CAD), according to the results of a randomized, controlled clinical trial presented at the annual meeting of the Radiological Society of North America (RSNA).